World News: 15:04 GMT Friday 9th November 2018. [Gradalis, Inc. via Globe Newswire via SPi World News]
DALLAS Nov 09 2018 GLOBE NEWSWIRE -- Gradalis, Inc a clinical-stage immunotherapy company developing investigational treatments for individuals suffering from multiple cancer indications presented initial data from its Phase 2 trial for Ew ing’s...
Globe Newswire: 15:04 GMT Friday 9th November 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.